Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • On the Market
  • Published:

Annexin-V imaging for noninvasive detection of cardiac allograft rejection

Abstract

Heart transplant rejection is characterized pathologically by myocyte necrosis and apoptosis associated with interstitial mononuclear cell infiltration. Any one of these components can be targeted for noninvasive detection of transplant rejection. During apoptotic cell death, phosphatidylserine, a phospholipid that is normally confined to the inner leaflet of cell membrane bilayer, gets exteriorized. Technetium-99m-labeled annexin-V, an endogenous protein that has high affinity for binding to phosphatidylserine, has been administered intravenously for noninvasive identification of apoptotic cell death. In the present study of 18 cardiac allograft recipients, 13 patients had negative and five had positive myocardial uptake of annexin. These latter five demonstrated at least moderate transplant rejection and caspase-3 staining, suggesting apoptosis in their biopsy specimens. This study reveals the clinical feasibility and safety of annexin-V imaging for noninvasive detection of transplant rejection by targeting cell membrane phospholipid alterations that are commonly associated with the process of apoptosis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Noninvasive imaging with 99mTc–annexin-V.
Figure 2: Diffuse myocardial uptake of 99mTc–annexin-V in cardiac allograft.
Figure 3: Pathologic characterization of EMB specimens.

References

  1. Billingham, M.E. et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation (ISHLT). J. Heart Transplant. 9, 587–593 (1990).

    CAS  PubMed  Google Scholar 

  2. Laguens, R.P., Cabeza-Mackert, P.M., San Martino, J., Perrone, S. & Favaloro, S. Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J. Heart Lung Transplant. 15, 911–918 (1996).

    CAS  PubMed  Google Scholar 

  3. Szablocs, M.J. et al. Apoptosis and increased expression of inducible nitric oxide synthetase in human allograft rejection. Transplantation 65, 804–812 (1998).

    Article  Google Scholar 

  4. Puig, M. et al. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. J. Nucl. Cardiol. 7, 132–139 (2000).

    Article  CAS  Google Scholar 

  5. Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C.P.M. A novel assay for apoptosis flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immuno. Methods 184, 39–51 (1995).

    Article  CAS  Google Scholar 

  6. Strauss, H.W., Narula, J., & Blankenberg, F.G. Radioimaging to identify myocardial cell death and probably injury. Lancet 356, 180–181 (2000).

    Article  CAS  Google Scholar 

  7. Blankenberg, F.G. et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA 95, 6349–6354 (1998).

    Article  CAS  Google Scholar 

  8. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501 (1992).

    Article  CAS  Google Scholar 

  9. Narula, N. et al. Is myofibrillarlytic myocyte an apoptotic myocyte? Mod. Pathol. 13, 52A (2000).

    Article  Google Scholar 

  10. Ohno, M. et al. Apoptotic myocytes in the infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electromicroscopy combined with in situ nick end labeling. Circulation 98, 1422–1430 (1998).

    Article  CAS  Google Scholar 

  11. Kanoh, M. et al. Significance of myocytes with positive DNA end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Circulation 99, 2757–2764 (1999).

    Article  CAS  Google Scholar 

  12. Hammond, E.H. et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J. Heart Transplant. 8, 430–443 (1989).

    CAS  PubMed  Google Scholar 

  13. Martin, S.J., Reutelingsperger, C.P.M. & McGahon AJ . Early redistribution of plasma membrane phosphatidylserine in a general feature of apoptosis regardless of the initiating stimulus. J. Exp. Med. 182, 1545–1556 (1995).

    Article  CAS  Google Scholar 

  14. Zwaal, R.F. & Schroit, A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89, 1121–1132 (1997).

    CAS  PubMed  Google Scholar 

  15. Fadok, V.A. et al. A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature 405, 85–90 (2000).

    Article  CAS  Google Scholar 

  16. Hofstra, L. et al. Visualization of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209–212 (2000).

    Article  CAS  Google Scholar 

  17. Verhoven, B., Schlegel, R.A. & Williamson, P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182, 1597–1601 (1995).

    Article  CAS  Google Scholar 

  18. Tait, J.F. & Gibson, D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J. Lab. Clin. Med. 123, 741–748 (1994).

    CAS  PubMed  Google Scholar 

  19. Kolodgie, F.D. et al. Tc-99m annexin V imaging for the noninvasive detection of experimental atherosclerotic lesions. Circulation. 102, 404 (2000).

    Google Scholar 

  20. Petrov, A. et al. Sarcolemmal phosphatidylserine expression in ischemic myocardial syndromes can be detected by Tc-99m annexin-V imaging. Circulation 102, 545 (2000).

    Google Scholar 

  21. Gottlieb, R.A., Burleson, K.O., Kloner, R.A., Babior, B.M. & Engler, R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94, 1621–1628 (1994).

    Article  CAS  Google Scholar 

  22. Kasina, S. et al. Development and biologic evaluation of kit for preformed chelate technetium-99m radiolabeling of an antibody fab fragment using a diamide dimercaptide chelating agent. J. Nucl. Med. 32, 1445–1451 (1991).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jagat Narula.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Narula, J., Acio, E., Narula, N. et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7, 1347–1352 (2001). https://doi.org/10.1038/nm1201-1347

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1201-1347

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing